Fri, July 26, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 11, 2024
Thu, May 16, 2024
[ 12:00 AM ] - WOPRAI
Fri, April 12, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 1, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 26, 2024
[ 12:00 AM ] - WOPRAI
Mon, March 25, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, March 6, 2024
[ 12:00 AM ] - WOPRAI
Tue, February 6, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, January 31, 2024
[ 12:00 AM ] - WOPRAI
Wed, November 29, 2023
[ 12:00 AM ] - WOPRAI
Fri, November 17, 2023
[ 12:00 AM ] - WOPRAI
Thu, November 2, 2023
[ 12:00 AM ] - WOPRAI
Fri, October 6, 2023
[ 12:00 AM ] - WOPRAI
Thu, October 5, 2023
Wed, October 4, 2023
[ 12:00 AM ] - WOPRAI
Mon, September 25, 2023
[ 12:00 AM ] - WOPRAI
Fri, September 15, 2023
[ 12:00 AM ] - WOPRAI
Tue, September 5, 2023
[ 12:00 AM ] - WOPRAI
Wed, August 16, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 15, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 8, 2023
[ 12:00 AM ] - WOPRAI
Fri, June 30, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 2, 2023
[ 12:00 AM ] - WOPRAI
Mon, February 13, 2023
[ 12:00 AM ] - WOPRAI
Thu, February 9, 2023
[ 12:00 AM ] - WOPRAI
Thu, January 5, 2023
[ 12:00 AM ] - WOPRAI
Wed, November 16, 2022
Robyn Karnauskas Reiterated (ABBV) at Strong Buy with Increased Target to $210 on, Jul 26th, 2024
Robyn Karnauskas of Truist Securities, Reiterated "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $195 to $210 on, Jul 26th, 2024.
Robyn has made no other calls on ABBV in the last 4 months.
There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 0 agree with Robyn's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Robyn
- Evan David Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $214 on, Friday, July 19th, 2024
- Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $196 on, Thursday, July 11th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy and Held Target at $190 on, Tuesday, July 2nd, 2024
- Rajesh Kumar of "HSBC" Upgraded from Hold to Strong Buy and Held Target at $185 on, Wednesday, June 5th, 2024
Contributing Sources